Literature DB >> 22510635

Prevention of maternal and congenital cytomegalovirus infection.

Julie Johnson1, Brenna Anderson, Robert F Pass.   

Abstract

Congenital cytomegalovirus (CMV) infection is an important cause of hearing impairment, mental retardation, and cerebral palsy. Principal sources of infection during pregnancy are young children and intimate contacts. Prevention of maternal and congenital CMV infection depends on counseling women regarding the sources of infection and hygienic measures that might prevent infection. There is currently insufficient evidence to support use of antiviral treatment or passive immunization for postexposure prophylaxis of pregnant women or as a maternal treatment aimed at preventing fetal infection. Vaccines for CMV are under development but it will be a number of years before one is licensed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510635      PMCID: PMC3347968          DOI: 10.1097/GRF.0b013e3182510b7b

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  32 in total

1.  Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk.

Authors:  C Liesnard; C Donner; F Brancart; F Gosselin; M L Delforge; F Rodesch
Journal:  Obstet Gynecol       Date:  2000-06       Impact factor: 7.661

2.  Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.

Authors:  Maria Grazia Revello; Emilia Genini; Giovanna Gorini; Catherine Klersy; Antonio Piralla; Giuseppe Gerna
Journal:  J Clin Virol       Date:  2010-06-18       Impact factor: 3.168

3.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype.

Authors:  Naeem Khan; Mark Cobbold; Russell Keenan; Paul A H Moss
Journal:  J Infect Dis       Date:  2002-03-25       Impact factor: 5.226

Review 5.  Congenital cytomegalovirus infection: review of the epidemiology and outcome.

Authors:  Michael A Gaytant; Eric A P Steegers; Ben A Semmekrot; Hans M M W Merkus; Jochem M D Galama
Journal:  Obstet Gynecol Surv       Date:  2002-04       Impact factor: 2.347

6.  Maternal immunity and prevention of congenital cytomegalovirus infection.

Authors:  Karen B Fowler; Sergio Stagno; Robert F Pass
Journal:  JAMA       Date:  2003-02-26       Impact factor: 56.272

7.  Prevention of child-to-mother transmission of cytomegalovirus among pregnant women.

Authors:  Stuart P Adler; Jack W Finney; Anne Marie Manganello; Al M Best
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

8.  Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

Authors:  David W Kimberlin; Chin-Yu Lin; Pablo J Sánchez; Gail J Demmler; Wayne Dankner; Mark Shelton; Richard F Jacobs; Wendy Vaudry; Robert F Pass; Jan M Kiell; Seng-jaw Soong; Richard J Whitley
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

9.  Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

Authors:  Rebecca Elkington; Susan Walker; Tania Crough; Moira Menzies; Judy Tellam; Mandvi Bharadwaj; Rajiv Khanna
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 10.  Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.

Authors:  Ann M Arvin; Patricia Fast; Martin Myers; Stanley Plotkin; Regina Rabinovich
Journal:  Clin Infect Dis       Date:  2004-06-25       Impact factor: 9.079

View more
  14 in total

1.  Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.

Authors:  Julie H Ishida; Tracy Burgess; Michael A Derby; Pearline A Brown; Mauricio Maia; Rong Deng; Brinda Emu; Becket Feierbach; Ashley E Fouts; X Charlene Liao; Jorge A Tavel
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

2.  Leucocyte adhesion deficiency type 1 with developmental delay secondary to CMV infection and filiation questions.

Authors:  Alexis Strickler; Silvanna Gallo; Alejandra King; Sergio D Rosenzweig
Journal:  BMJ Case Rep       Date:  2015-04-09

3.  Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout Swine.

Authors:  Mitsuhiro Sekijima; Shiori Waki; Hisashi Sahara; Masayuki Tasaki; Robert A Wilkinson; Vincenzo Villani; Yoshiki Shimatsu; Kazuaki Nakano; Hitomi Matsunari; Hiroshi Nagashima; Jay A Fishman; Akira Shimizu; Kazuhiko Yamada
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 4.  Novel approaches for vaccine development.

Authors:  Makda S Gebre; Luis A Brito; Lisa H Tostanoski; Darin K Edwards; Andrea Carfi; Dan H Barouch
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

Review 5.  Cytomegalovirus in the neonate: immune correlates of infection and protection.

Authors:  Mark R Schleiss
Journal:  Clin Dev Immunol       Date:  2013-08-19

6.  Congenital cytomegalovirus reference material: a content analysis of coverage and accuracy.

Authors:  Rosemary Thackeray; Allison Wright; Katherine Chipman
Journal:  Matern Child Health J       Date:  2014-04

7.  Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children.

Authors:  Michael J Cannon; Jennifer D Stowell; Rebekah Clark; Philip R Dollard; Delaney Johnson; Karen Mask; Cynthia Stover; Karen Wu; Minal Amin; Will Hendley; Jing Guo; D Scott Schmid; Sheila C Dollard
Journal:  BMC Infect Dis       Date:  2014-11-13       Impact factor: 3.090

8.  Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.

Authors:  Jennifer A Jenks; Cody S Nelson; Hunter K Roark; Matthew L Goodwin; Robert F Pass; David I Bernstein; Emmanuel B Walter; Kathryn M Edwards; Dai Wang; Tong-Ming Fu; Zhiqiang An; Cliburn Chan; Sallie R Permar
Journal:  Sci Transl Med       Date:  2020-11-04       Impact factor: 19.319

9.  Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico.

Authors:  Cosme Alvarado-Esquivel; Jesús Hernández-Tinoco; Luis Francisco Sánchez-Anguiano; Agar Ramos-Nevárez; Sandra Margarita Cerrillo-Soto; Sergio Estrada-Martínez; Lucio Martínez-Ramírez; Alma Rosa Pérez-Álamos; Carlos Alberto Guido-Arreola
Journal:  BMC Infect Dis       Date:  2014-09-05       Impact factor: 3.090

10.  Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia.

Authors:  S Giovanoli; H Engler; A Engler; J Richetto; J Feldon; M A Riva; M Schedlowski; U Meyer
Journal:  Transl Psychiatry       Date:  2016-04-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.